• The chemotherapy of leishmaniasis is still far from satisfactory. Itraconazole, one of the most recent azole antifungal agents, appears to be well tolerated in man. Two patients with cutaneous leishmaniasis (Leishmania tropica), contracted in Saudi Arabia, were treated orally for 2 months with itraconazole (100 mg/d). Both recovered without side effects or abnormalities in their main biologic parameters.
(Arch Dermatol. 1989;125:1540-1542)
Albanese G, Giorgetti P, Santagostino L, Crippa D, Sala G. Cutaneous Leishmaniasis: Treatment With Itraconazole. Arch Dermatol. 1989;125(11):1540–1542. doi:10.1001/archderm.1989.01670230082014
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.